<VariationArchive VariationID="208983" VariationName="NM_001082486.2(ACD):c.250_252del (p.Lys84del)" VariationType="Deletion" Accession="VCV000208983" Version="10" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2016-06-26" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="205538" VariationID="208983">
      <GeneList>
        <Gene Symbol="ACD" FullName="ACD shelterin complex subunit and telomerase recruitment factor" GeneID="65057" HGNC_ID="HGNC:25070" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67657512" stop="67660260" display_start="67657512" display_stop="67660260" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67691414" stop="67694717" display_start="67691414" display_stop="67694717" Strand="-" />
          </Location>
          <OMIM>609377</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACD">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001082486.2(ACD):c.250_252del (p.Lys84del)</Name>
      <CanonicalSPDI>NC_000016.10:67659785:CTTCT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67659786" stop="67659788" display_start="67659786" display_stop="67659788" variantLength="3" positionVCF="67659785" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67693689" stop="67693691" display_start="67693689" display_stop="67693691" variantLength="3" positionVCF="67693688" referenceAlleleVCF="CCTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K84del</ProteinChange>
      <ProteinChange>K81del</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1237" sequenceAccession="LRG_1237" change="g.6028_6030del">
            <Expression>LRG_1237:g.6028_6030del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1237t1" sequenceAccession="LRG_1237t1" change="c.250_252del">
            <Expression>LRG_1237t1:c.250_252del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1237p1" sequenceAccession="LRG_1237p1" change="p.Lys84del">
            <Expression>LRG_1237p1:p.Lys84del</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67659788_67659790del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67659788_67659790del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67693691_67693693del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67693691_67693693del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042874.1" sequenceAccession="NG_042874" sequenceVersion="1" change="g.6028_6030del">
            <Expression>NG_042874.1:g.6028_6030del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001082486.2" sequenceAccession="NM_001082486" sequenceVersion="2" change="c.250_252del" MANESelect="true">
            <Expression>NM_001082486.2:c.250_252del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001075955.2" sequenceAccession="NP_001075955" sequenceVersion="2" change="p.Lys84del">
            <Expression>NP_001075955.2:p.Lys84del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022914.3" sequenceAccession="NM_022914" sequenceVersion="3" change="c.241_243del">
            <Expression>NM_022914.3:c.241_243del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075065.3" sequenceAccession="NP_075065" sequenceVersion="3" change="p.Lys81del">
            <Expression>NP_075065.3:p.Lys81del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_001075955.1" sequenceAccession="NP_001075955" sequenceVersion="1" change="p.Lys170del">
            <Expression>NP_001075955.1:p.Lys170del</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA214612" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="609377.0001" DB="OMIM" />
        <XRef Type="rs" ID="797045144" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001082486.2(ACD):c.250_252del (p.Lys84del) AND Dyskeratosis congenita, autosomal recessive 7" Accession="RCV000190904" Version="7">
        <ClassifiedConditionList TraitSetID="22741">
          <ClassifiedCondition DB="MedGen" ID="C4225283">Dyskeratosis congenita, autosomal recessive 7</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-10-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001082486.2(ACD):c.250_252del (p.Lys84del) AND Dyskeratosis congenita, autosomal dominant 6" Accession="RCV000190903" Version="14">
        <ClassifiedConditionList TraitSetID="22740">
          <ClassifiedCondition DB="MedGen" ID="C4225284">Dyskeratosis congenita, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-31" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-31" NumberOfSubmissions="4" NumberOfSubmitters="3" DateCreated="2016-06-26" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25205116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25233904</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27807141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31515401</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301779</ID>
          <ID Source="BookShelf">NBK22301</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22740" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34297" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0014690" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCA6</ElementValue>
                <XRef Type="MIM" ID="616553" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16136" />
                <XRef ID="16136" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="3322" DB="Orphanet" />
              <XRef ID="C4225284" DB="MedGen" />
              <XRef ID="MONDO:0014690" DB="MONDO" />
              <XRef Type="MIM" ID="616553" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22741" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="34298" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 7</ElementValue>
                <XRef ID="MONDO:0800370" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCB7</ElementValue>
                <XRef ID="616553" DB="OMIM" />
              </Symbol>
              <XRef ID="C4225283" DB="MedGen" />
              <XRef ID="MONDO:0800370" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="533170" SubmissionDate="2016-06-16" DateLastUpdated="2022-10-01" DateCreated="2016-06-26">
        <ClinVarSubmissionID localKey="NM_001082486.1:c.508_510delAAG|OMIM:616553" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000282031" DateUpdated="2022-10-01" DateCreated="2016-06-26" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25233904</ID>
          </Citation>
          <Citation>
            <ID Source="BookShelf">NBK22301</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_001075955.1:p.Lys170del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001082486.1:c.508_510delAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225284" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="455228" SubmissionDate="2021-10-13" DateLastUpdated="2022-12-31" DateCreated="2015-09-20">
        <ClinVarSubmissionID localKey="609377.0001_DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7" title="ACD, 3-BP DEL, AAG_DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7" />
        <ClinVarAccession Accession="SCV000245778" DateUpdated="2022-12-31" DateCreated="2015-09-20" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 female members in 3 subsequent generations of a family with autosomal dominant dyskeratosis congenita-6 (DKCA6; 616553) manifest as progressive bone marrow failure, Guo et al. (2014) identified a heterozygous in-frame 3-bp deletion (c.499_501del, NM_001082486.1) in the ACD gene, resulting in the deletion of conserved residue lys170 (K170del). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family and was not found in public databases. Lys170 localizes to the surface of the TPP1 protein known as the TEL patch, known to be vital for binding to telomerase. Transfection of the mutant protein into 293T cells showed that it localized properly onto telomeres similar to wildtype, but was unable to recruit telomerase to the telomeres.</Attribute>
              <Citation>
                <ID Source="PubMed">25205116</ID>
              </Citation>
              <XRef DB="OMIM" ID="616553" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a boy with autosomal recessive dyskeratosis congenita-7 (DKCB7; see 616553) manifest as Hoyeraal-Hreidarsson syndrome, Kocak et al. (2014) identified compound heterozygous mutations in the ACD gene: a 3-bp deletion (c.508_510delAAG, NM_001082486.1), resulting in K170del, which was inherited from his father who had premature graying of the hair, short telomeres, and mild dental abnormalities, and a c.1471C-A transversion, resulting in a pro491-to-thr (P491T; 609377.0002) substitution at a conserved residue in the C-terminal TIN2-interacting domain, which was inherited from the unaffected mother. The mutations were found by whole-exome sequencing and confirmed by Sanger sequencing. The K170del mutation was not found in the dbSNP (build 137), 1000 Genomes Project, or Exome Sequencing Project (ESP) databases or in an in-house control database. The P401T variant was found in the dbSNP database and in the ESP database at a low frequency (0.0002). It was not present in the 1000 Genomes Project database or in the in-house control database. In vitro functional expression assays in HeLa cells showed that the K170del mutant compromised telomerase recruitment to telomeres and reduced telomerase enzymatic processivity compared to wildtype. The P491T mutant efficiently colocalized with the RNA component of telomerase (TR; 602322) on telomeres and did not interfere with telomerase interaction with TPP1 (encoded by ACD) or processivity, but it did cause a modest (2-fold) reduction in TIN2 (604319) association. Kocak et al. (2014) concluded that the detrimental effect of the P491T mutation was modest compared to the effect of the K170del mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">25233904</ID>
              </Citation>
              <XRef DB="OMIM" ID="616553" Type="MIM" />
              <XRef DB="OMIM" ID="602322" Type="MIM" />
              <XRef DB="OMIM" ID="604319" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACD" />
          </GeneList>
          <Name>ACD, 3-BP DEL, AAG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, AAG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609377.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="455227" SubmissionDate="2021-10-14" DateLastUpdated="2024-06-09" DateCreated="2015-09-20">
        <ClinVarSubmissionID localKey="609377.0001_DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6 (1 family)" title="ACD, 3-BP DEL, AAG_DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6 (1 family)" />
        <ClinVarAccession Accession="SCV000245777" DateUpdated="2024-06-09" DateCreated="2015-09-20" Type="SCV" Version="8" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 female members in 3 subsequent generations of a family with autosomal dominant dyskeratosis congenita-6 (DKCA6; 616553) manifest as progressive bone marrow failure, Guo et al. (2014) identified a heterozygous in-frame 3-bp deletion (c.499_501del, NM_001082486.1) in the ACD gene, resulting in the deletion of conserved residue lys170 (K170del). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family and was not found in public databases. Lys170 localizes to the surface of the TPP1 protein known as the TEL patch, known to be vital for binding to telomerase. Transfection of the mutant protein into 293T cells showed that it localized properly onto telomeres similar to wildtype, but was unable to recruit telomerase to the telomeres.</Attribute>
              <Citation>
                <ID Source="PubMed">25205116</ID>
              </Citation>
              <XRef DB="OMIM" ID="616553" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a boy with autosomal recessive dyskeratosis congenita-7 (DKCB7; see 616553) manifest as Hoyeraal-Hreidarsson syndrome, Kocak et al. (2014) identified compound heterozygous mutations in the ACD gene: a 3-bp deletion (c.508_510delAAG, NM_001082486.1), resulting in K170del, which was inherited from his father who had premature graying of the hair, short telomeres, and mild dental abnormalities, and a c.1471C-A transversion, resulting in a pro491-to-thr (P491T; 609377.0002) substitution at a conserved residue in the C-terminal TIN2-interacting domain, which was inherited from the unaffected mother. The mutations were found by whole-exome sequencing and confirmed by Sanger sequencing. The K170del mutation was not found in the dbSNP (build 137), 1000 Genomes Project, or Exome Sequencing Project (ESP) databases or in an in-house control database. The P401T variant was found in the dbSNP database and in the ESP database at a low frequency (0.0002). It was not present in the 1000 Genomes Project database or in the in-house control database. In vitro functional expression assays in HeLa cells showed that the K170del mutant compromised telomerase recruitment to telomeres and reduced telomerase enzymatic processivity compared to wildtype. The P491T mutant efficiently colocalized with the RNA component of telomerase (TR; 602322) on telomeres and did not interfere with telomerase interaction with TPP1 (encoded by ACD) or processivity, but it did cause a modest (2-fold) reduction in TIN2 (604319) association. Kocak et al. (2014) concluded that the detrimental effect of the P491T mutation was modest compared to the effect of the K170del mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">25233904</ID>
              </Citation>
              <XRef DB="OMIM" ID="616553" Type="MIM" />
              <XRef DB="OMIM" ID="602322" Type="MIM" />
              <XRef DB="OMIM" ID="604319" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACD" />
          </GeneList>
          <Name>ACD, 3-BP DEL, AAG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, AAG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609377.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6 (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4321825" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4932702|MedGen:C4225284" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002298144" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25205116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25233904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27807141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25205116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25233904</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31515401</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects ACD function (PMID: 25205116, 25233904, 27807141). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 208983). This variant has been observed in individual(s) with clinical features of dyskeratosis congenita (PMID: 25205116, 25233904, 31515401; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This variant, c.508_510del, results in the deletion of 1 amino acid(s) of the ACD protein (p.Lys170del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.67693689_67693691del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225284" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="455227" TraitType="Disease" MappingType="Name" MappingValue="DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6 (1 family)" MappingRef="Preferred">
        <MedGen CUI="C4225284" Name="Dyskeratosis congenita, autosomal dominant 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="533170" TraitType="Disease" MappingType="XRef" MappingValue="C4225284" MappingRef="MedGen">
        <MedGen CUI="C4225284" Name="Dyskeratosis congenita, autosomal dominant 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4321825" TraitType="Disease" MappingType="XRef" MappingValue="C4225284" MappingRef="MedGen">
        <MedGen CUI="C4225284" Name="Dyskeratosis congenita, autosomal dominant 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="455228" TraitType="Disease" MappingType="Name" MappingValue="DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 7" MappingRef="Alternate">
        <MedGen CUI="C4225283" Name="Dyskeratosis congenita, autosomal recessive 7" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

